Evidence map›Paper›PMID 31293911›Full record

ArticleJournal of clinical and translational hepatology2019

Transplantation of HCV Viremic Livers into HCV Viremic Recipients Followed by Direct-acting Antiviral Therapy.

Nikhil Kapila, Kawtar Al Khalloufi, Gianina Flocco, K V Narayanan Menon, Christina Lindenmeyer, Diego Reino, Jason M Vanatta, Samer Ebaid, Andreas Tzakis, Xaralambos Bobby Zervos

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical and translational hepatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Prophylactic 2-week glecaprevir/pibrentasvir in hepatitis C positive-to-negative kidney transplantation.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
    Article
  2. Review
  3. [Progress in antiviral treatment of hepatitis C after liver transplantation].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Nikhil KapilaDepartment of Gastroenterology and Hepatology, Cleveland Clinic Florida, Weston, FL, USA.
Kawtar Al KhalloufiDepartment of Transplant, Cleveland Clinic Florida, Weston, FL, USA.
Gianina FloccoDepartment of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, OH, USA.
K V Narayanan MenonDepartment of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, OH, USA.
Christina LindenmeyerDepartment of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, OH, USA.
Diego ReinoDepartment of Transplant, Cleveland Clinic Florida, Weston, FL, USA.
Jason M VanattaDepartment of Transplant, Cleveland Clinic Florida, Weston, FL, USA.
Samer EbaidDepartment of Transplant, Cleveland Clinic Florida, Weston, FL, USA.
Andreas TzakisDepartment of Transplant, Cleveland Clinic Florida, Weston, FL, USA.
Xaralambos Bobby ZervosDepartment of Transplant, Cleveland Clinic Florida, Weston, FL, USA.
Cleveland Clinic Florida · USCleveland Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Direct-acting antiviral agentsDonor pool expansionHepatitis CHigh risk donorsLiver transplantation

Identifiers

PMID31293911
PMCPMC6609846
OpenAlexW2948363232

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.